Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Drug Control Sri Lanka
A Broken System: Drug Control, Detention and Treatment of People Who Use Drugs in Sri Lanka.
A Broken System: Drug Control, Detention and Treatment of People Who Use Drugs in Sri Lanka.
Services now ‘on their knees’, says Carol Black
"Funding cuts have left treatment and recovery services ‘on their knees’, commissioning has ‘become fragmented with little accountability for outcomes’ and partnerships between local authorities and health and criminal justice agencies have deteriorated across the country" Professor Dame Carol Black
"Funding cuts have left treatment and recovery services ‘on their knees’, commissioning has ‘become fragmented with little accountability for outcomes’ and partnerships between local authorities and health and criminal justice agencies have deteriorated across the country" Professor Dame Carol Black
The Harms of Incarceration
The evidence base and human rights framework for decarceration and harm reduction in prisons
The evidence base and human rights framework for decarceration and harm reduction in prisons
Give a helping hand, not handcuffs: Social decriminalization campaign in Lithuania
This year “Young Wave” has focused small grant activities on the development of the social campaign. Why have you chosen such kind of activity? Could you please tell us what your campaign is about?
This year “Young Wave” has focused small grant activities on the development of the social campaign. Why have you chosen such kind of activity? Could you please tell us what your campaign is about?
INPUD Annual Report and Financial Summaries: 2020
The INPUD report is a celebration of the incredible accomplishments of our network and the global community of people who use drugs over this past year. Despite facing down unprecedented challenges posed by the COVID-19 pandemic, decreasing funding spaces and reactionary pushback on human rights, peers across the world stepped up in incredible and inspiring ways. INPUD's work in 2020 was some of our most impactful yet, and we are so grateful to all of our members, donors and supporters who helped us achieve this incredible work.
The INPUD report is a celebration of the incredible accomplishments of our network and the global community of people who use drugs over this past year. Despite facing down unprecedented challenges posed by the COVID-19 pandemic, decreasing funding spaces and reactionary pushback on human rights, peers across the world stepped up in incredible and inspiring ways. INPUD's work in 2020 was some of our most impactful yet, and we are so grateful to all of our members, donors and supporters who helped us achieve this incredible work.
Opioid Agonist Therapy (OAT) associated with lower risk of multiple causes of death for people with opioid dependence
A new global review has found that receiving Opioid Agonist Therapy (OAT) is associated with lower risk of multiple causes of death among people with opioid dependence.
A new global review has found that receiving Opioid Agonist Therapy (OAT) is associated with lower risk of multiple causes of death among people with opioid dependence.
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic
In this cohort study of 83.7 million EMS patient encounters, overdose-associated cardiac arrests rose about 40% nationally in 2020, with the largest increases among racial/ethnic minorities, in areas of socioeconomic disadvantage, and in Western states. High concordance was observed with provisional total overdose death figures through July 2020.
In this cohort study of 83.7 million EMS patient encounters, overdose-associated cardiac arrests rose about 40% nationally in 2020, with the largest increases among racial/ethnic minorities, in areas of socioeconomic disadvantage, and in Western states. High concordance was observed with provisional total overdose death figures through July 2020.
“Nothing to mourn,..........” - stigma towards people bereaved by drug-related death
Although mortality attributed to illicit drugs is a significant contributor to the overall number of deaths worldwide, knowledge relating to the consequences for those bereaved by drug-related deaths (DRDs) is scarce. Since individuals with substance use disorders are prone to stigma, there is an urgent need for knowledge about the occurrence and content of stigmatization of those bereaved by DRDs.
Although mortality attributed to illicit drugs is a significant contributor to the overall number of deaths worldwide, knowledge relating to the consequences for those bereaved by drug-related deaths (DRDs) is scarce. Since individuals with substance use disorders are prone to stigma, there is an urgent need for knowledge about the occurrence and content of stigmatization of those bereaved by DRDs.
Prohibition, Privilege and the Drug Apartheid: The failure of drug policy reform to address the underlying fallacies of drug prohibition.
Alternative models of legalisation, decriminalisation and regulation are emerging across the world. Whilst critics have asserted that prohibition and the ensuing ‘war on drugs’ lack both an evidence base and legitimacy, reformers are embracing these alternatives as indicators of progressive change. This paper, however, argues that such reforms adhere to the same arbitrary notions, moral dogma and fallacious evidence base as their predecessor.
Alternative models of legalisation, decriminalisation and regulation are emerging across the world. Whilst critics have asserted that prohibition and the ensuing ‘war on drugs’ lack both an evidence base and legitimacy, reformers are embracing these alternatives as indicators of progressive change. This paper, however, argues that such reforms adhere to the same arbitrary notions, moral dogma and fallacious evidence base as their predecessor.
Drug-related deaths and mortality in Europe
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths.
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths.
